Diego de la Fuente

Diego de la Fuente is a highly accomplished Global Advocacy and Market Access senior leader with over 15 years of experience in the pharmaceutical and biotechnology industry.

Diego has a proven track record of delivering key leadership, strategies, and insights to enhance market outreach and patient access to critical drugs, having contributed to the success of various novel therapies like Rydapt, Adakveo, Xarelto, Jaydess, and Humira.

He is skilled at establishing strong alliances with country-specific HMOs, patient organizations, and other stakeholders to ensure cutting-edge therapies reach a broad patient base.

Diego possesses a deep understanding of global health systems, market dynamics, and HTA agencies, enabling him to drive business growth in diverse regions such as Latin America, North America, and Europe.

As a leader, Diego excels in building and optimizing high-performing access teams, fostering cross-functional collaboration, and driving strategic partnerships to achieve business goals.

His core strengths include patient engagement, global market access, senior-level leadership, clinical trials management, pricing strategies, and strategic planning.

Diego's educational background includes postgraduate studies in Strategic Performance Management in Health and MSc in Health Policy Planning and Financing.

He has held key positions in reputable organizations like Biogen, Novartis, Bayer Health Care, and Abbott Laboratories, where he has demonstrated expertise in market access, advocacy, and value proposition development.

Diego's professional journey also includes roles in Roche Pharmaceuticals and FUNSALUD, highlighting his diverse experience in the healthcare sector.

His skills in team building, strategic partnerships, market expansion, and competitive intelligence have been instrumental in his successful career in the pharmaceutical industry.